411 New York
Oops! Unsupported Browser

Jump to content



Photo

Dr. Reddy's Laboratories Continues its Voluntary Nationwide Recall of L


  • Please log in to reply
No replies to this topic

#1 Pinkfish

Pinkfish

    Level 7

  • Contributor
  • 44,662 posts
  • Gender:Female
  • City:Florida
  • Country:United States

Posted 04 February 2019 - 10:21 AM

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it’s wholly owned subsidiary, Dr Reddy’s Laboratories, Inc is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags to the hospital level in U.S.A.

View the full article from the FDA.




0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users